Landry John reported grant involving 186,447 derivative units of CVRx, Inc. at $0.00 for $0 on Nov 9, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Financial Officer
Chief Financial Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
186,447Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
186,447Direct
Trade date
Nov 9, 2026Grant
Filed
Nov 12, 2026, 4:17 PM ET3-day reporting delay
Accession
0001753455-26-000007Code A · Transaction 398893
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Grant41,433$0.00$0Trade 398892
2 transaction rows in this filing. Joint filers share the same rows.

CVRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CVRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +11%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of October 12, 2026. F2: Vests as to 25% of the shares on October 12, 2027 and as to 1/48th of the shares each month thereafter.